Historical record - last NADAC effective date: 1/19/2022
Product Information
MORPHINE SULFATE ER 30 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $3.3842 per EA under NDC 00115127801. Its NADAC has been published 267 times since Feb 8, 2017.
FDA first approved this application on Apr 12, 2016.
Strength
30 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115127801
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
1/19/2022
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA200411FDA Approved
4/12/2016
On Market Since
4/12/2016
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 30 MG CAP has been published 267 times since Feb 8, 2017, and over the history we have for it it has risen 13.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3842 per EA |
|---|---|
| All-time high | $3.6410 (Jan 10, 2018) |
| All-time low | $1.8067 (Oct 23, 2019) |
| Median price | $2.8177 |
| Average price | $2.8712 |
| Largest weekly change | +51.3% (Nov 18, 2020) |
| Weeks tracked | 267 |
| Tracking since | Feb 8, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+20.1%
All
+13.5%
Last surveyed Mar 16, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MORPHINE SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 30 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $3.3842 per EA (NDC 00115127801), effective Mar 16, 2022.
How has the price of MORPHINE SULFATE ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 30 MG CAP has risen 13.5%. It has been tracked across 267 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 30 MG CAP?
Since Feb 8, 2017, the NADAC for MORPHINE SULFATE ER 30 MG CAP has ranged from a low of $1.8067 (Oct 23, 2019) to a high of $3.6410 (Jan 10, 2018), with a median of $2.8177 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 30 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE SULFATE ER 30 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE ER 30 MG CAP?
MORPHINE SULFATE ER 30 MG CAP (NDC 00115127801) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.